Please assess the completion status of the following clinical trial:

Trial Title: Vascular Implications of a Naturally Occurring Asthma Exacerbation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* between the ages of 18 and 55 years old~* waist circumference less than 88 cm for women and 102 cm for men.~* Asthma participants will be recruited from the University of Alberta Emergency Department with asthma exacerbation as their primary reason for visit.~* healthy controls will be recruited from the general population according to the same criteria, but with no history of asthma.~Exclusion Criteria:~* known heart failure or unstable cardiac disease,~* lung diseases other than asthma,~* known chronic inflammatory condition other than asthma~* known metabolic disease~* current infections,~* smoking history \> 10 pack years,~* or waist circumference \>88 cm for women and \>102 cm for men

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Control (Type: None): Healthy controls will be recruited from the general population and will be matched based on age, sex, and BMI. They will be assess at two time points, 48 hours apart. At each testing day, a blood sample will be taken, and endothelial function will be assessed using brachial artery flow mediated dilation. Arterial stiffness will be assessed using carotid-radial pulse wave velocity.
- Asthma (Type: None): Individuals experiencing an asthma exacerbation will be recruited from the University of Alberta Hospital Emergency Department. Once discharged, a blood sample will be taken, and endothelial function will be assessed using brachial artery flow mediated dilation. Arterial stiffness will be assessed using carotid-radial pulse wave velocity. Participants will complete the same assessments at a follow up date 48 hours and 14 days post-discharge, with the addition of a full pulmonary function test, physical activity assessment via a Fitbit, and the completion of two questionnaires: Asthma Control Questionnaire, and Asthma Quality of Life Questionnaire.

Based on this trial design, predict the completion outcome and termination type (if applicable).